13F

Stock

Protalix BioTherapeutics, Inc.

PLX · held by 2 managers

Reported value

$58.5K

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$4.5K

Price effect on 2 books still in the name

Largest holder

$41.5K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC35.4K$41.5K−$3.19KCut−$62.4K
Finivi Inc.14.5K$17K−$1.31KCut−$1.31K

Positions as of Q2 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.